Abstract
This review aims to explore the advancements in long-acting injectable therapies [LAI] that are revolutionizing cancer treatment. With cancer posing a significant global health challenge, conventional treatments often come with limitations, including harmful side effects and resistance development. Long-acting formulations (LAFs), particularly those manipulating medication release through delivery systems, present a promising alternative. The review delves into various LAF approaches, such as micro-encapsulation, liposomes, oil-based LAPFs, nanocrystal suspensions, longacting hydrogels, microneedles, and implantable systems. These approaches offer sustained release, reduced toxicity, and improved therapeutic efficacy. The review highlights the benefits and disadvantages of LAIs, emphasizing improved adherence, reduced risk of relapse, and enhanced quality of life. Evaluation parameters, including pharmacokinetics, biocompatibility, stability, mechanical properties, and safety, are discussed. The comprehensive assessment underscores the ongoing efforts in oncological research to develop innovative and effective therapies that address the challenges associated with conventional cancer treatments.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
